Stempeutics partners with Kemwell for global development and commercialisation of stem cell… EP News Bureau Jul 26, 2019 Under the agreement, Kemwell will take a minority stake in Stempeutics and invest up to Rs 950 million
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy Usha Sharma May 30, 2016 Stempeucel is used in the treatment of Buerger’s disease
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’ Usha Sharma Jun 8, 2015 Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
